Blockade of the CLCF1-CNTFR axis enhances the efficacy of GPC3 CAR-T cell therapy in hepatocellular carcinoma.
Zhang H, Pan Q, Xiang T, Huang L, Zhong H, Yang X, Li Y, Luo J, Chen H, Tang Y, Wang Q, He J, Gao S, Yang C, Xia J.
Zhang H, et al. Among authors: tang y.
Pharmacol Res. 2026 May 6:108209. doi: 10.1016/j.phrs.2026.108209. Online ahead of print.
Pharmacol Res. 2026.
PMID: 42102942